| Lipid Composition for CPGG-501 | Concentration (mg/ml) | Concentration (mM) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC) | 4.74 | 6 | 60 |
| Cholesterol | 1.16 | 3 | 30 |
| 1,2-distearoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt) (DSPG) | 0.40 | 0.5 | 5 |
| 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (ammonium salt) (DSPE-PEG2000) | 1.40 | 0.5 | 5 |
| Total | 7.70 mg/ml | 10 mM | 100 |
| Lipid Composition for CPGG-502 | Concentration (mg/ml) | Concentration (mM) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) | 4.72 | 6 | 60 |
| Cholesterol | 1.16 | 3 | 30 |
| 1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol (sodium salt) (DOPG) | 0.40 | 0.5 | 5 |
| 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (ammonium salt) (DOPE-PEG2000) | 1.40 | 0.5 | 5 |
| Total | 7.68 mg/ml | 10 mM | 100 |
| Lipid Composition for CPSG-501 | Concentration (mg/ml) | Concentration (mM) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC) | 4.74 | 6 | 60 |
| Cholesterol | 1.16 | 3 | 30 |
| 1,2-distearoyl-sn-glycero-3-phospho-L-serine (sodium salt) (DSPS) | 0.41 | 0.5 | 5 |
| 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (ammonium salt) (DSPE-PEG2000) | 1.40 | 0.5 | 5 |
| Total | 7.71 mg/ml | 10 mM | 100 |
| Lipid Composition for CPSG-502 | Concentration (mg/ml) | Concentration (mM) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) | 4.72 | 6 | 60 |
| Cholesterol | 1.16 | 3 | 30 |
| 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (sodium salt) (DOPS) | 0.40 | 0.5 | 5 |
| 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (ammonium salt) (DOPE2000) | 1.40 | 0.5 | 5 |
| Total | 7.68 mg/ml | 10 mM | 100 |
